Identification and Verification of Potential Biomarkers in Renal Ischemia-Reperfusion Injury by Integrated Bioinformatic Analysis

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2023 Feb 13

PMID 36778059

Authors

Ziwen Pan

Yuanyuan Yang

Rui Cao

Yang Qiu

Shanglin Li

Yuanyuan Zhao

Sheng Chang

Song Chen

Zhishui Chen

Weijie Zhang

Daqiang Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Renal ischemia-reperfusion injury (RIRI) plays an important role in the poor prognosis of patients with renal transplants. However, the potential targets and mechanism of IRI are still unclear.

Method: Differential gene expression (DEG) analysis and weighted correlation network analysis (WGCNA) were performed on the GSE27274 dataset. Pathway enrichment analysis on the DEGs was performed. To identify the hub DEGs, we constructed a protein-protein interaction (PPI) network. Finally, the hub genes were verified, and candidate drugs were screened from the DsigDB database.

Results: A hundred DEGs and four hub genes (, , , and ) were screened out. Pathway enrichment analysis revealed that 100 DEGs were mainly enriched in apoptosis and the TNF signaling pathway. The four hub genes were verified in animal models and another dataset (GSE148420). Thereafter, a PPI network was used to identify the four hub genes (, , , and ). Finally, eight candidate drugs were identified as potential drugs.

Conclusion: Three hub genes (, , and ) were associated with RIRI and could be potential novel biomarkers for RIRI.

Citing Articles

Identification of renal ischemia reperfusion injury-characteristic genes, pathways and immunological micro-environment features through bioinformatics approaches.

Lv X, Fan Q, Li X, Li P, Wan Z, Han X Aging (Albany NY). 2024; 16(3):2123-2140.

PMID: 38329418 PMC: 10911371. DOI: 10.18632/aging.205471.

Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease.

Trambas I, Coughlan M, Tan S Int J Mol Sci. 2023; 24(10).

PMID: 37240105 PMC: 10218149. DOI: 10.3390/ijms24108758.

References

Bao N, Dai D . Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats. Mediators Inflamm. 2020; 2020:2120971. PMC: 7157761. DOI: 10.1155/2020/2120971. View

Li Y, Xu B, Yang J, Wang L, Tan X, Hu X . Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release. Pharmacol Res. 2021; 173:105867. DOI: 10.1016/j.phrs.2021.105867. View

Clough E, Barrett T . The Gene Expression Omnibus Database. Methods Mol Biol. 2016; 1418:93-110. PMC: 4944384. DOI: 10.1007/978-1-4939-3578-9_5. View

Gong Y, Xu F, Deng L, Peng L . Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network. Biomed Res Int. 2022; 2022:2244228. PMC: 9247818. DOI: 10.1155/2022/2244228. View

Basler M, Dajee M, Moll C, Groettrup M, Kirk C . Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. J Immunol. 2010; 185(1):634-41. DOI: 10.4049/jimmunol.0903182. View

Zeng F, Shi M, Xiao H, Chi X . WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease. Biomed Res Int. 2021; 2021:5633211. PMC: 8687832. DOI: 10.1155/2021/5633211. View

Liu C, Zhou J, Wang B, Zheng Y, Liu S, Yang W . Bortezomib alleviates myocardial ischemia reperfusion injury via enhancing of Nrf2/HO-1 signaling pathway. Biochem Biophys Res Commun. 2021; 556:207-214. DOI: 10.1016/j.bbrc.2021.03.154. View

Quiroga I, McShane P, Koo D, Gray D, Friend P, Fuggle S . Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant. 2006; 21(6):1689-96. DOI: 10.1093/ndt/gfl042. View

de Vries B, Matthijsen R, Wolfs T, van Bijnen A, Heeringa P, Buurman W . Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation. 2003; 75(3):375-82. DOI: 10.1097/01.TP.0000044455.05584.2A. View

10.

Zhang J, Zhang J, Ni H, Wang Y, Katwal G, Zhao Y . Downregulation of XBP1 protects kidney against ischemia-reperfusion injury via suppressing HRD1-mediated NRF2 ubiquitylation. Cell Death Discov. 2021; 7(1):44. PMC: 7925512. DOI: 10.1038/s41420-021-00425-z. View

11.

Wu X, Zheng Y, Liu M, Li Y, Ma S, Tang W . BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains. Autophagy. 2020; 17(8):1934-1946. PMC: 8386707. DOI: 10.1080/15548627.2020.1802089. View

12.

Yoo M, Shin J, Kim J, Ryall K, Lee K, Lee S . DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015; 31(18):3069-71. PMC: 4668778. DOI: 10.1093/bioinformatics/btv313. View

13.

Zhao H, Alam A, Pac Soo A, George A, Ma D . Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond. EBioMedicine. 2018; 28:31-42. PMC: 5835570. DOI: 10.1016/j.ebiom.2018.01.025. View

14.

Lee S, Hur E, Ryoo I, Jung K, Kwak J, Kwak M . Involvement of the Nrf2-proteasome pathway in the endoplasmic reticulum stress response in pancreatic β-cells. Toxicol Appl Pharmacol. 2012; 264(3):431-8. DOI: 10.1016/j.taap.2012.08.021. View

15.

Shi C, Zhu Y, Bruins L, de Campos C, Stewart W, Braggio E . Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity. Mol Cancer Res. 2020; 18(10):1453-1464. PMC: 7541608. DOI: 10.1158/1541-7786.MCR-19-1026. View

16.

Jahn N, Sack U, Stehr S, Voelker M, Laudi S, Seehofer D . The Role of Innate Immune Cells in the Prediction of Early Renal Allograft Injury Following Kidney Transplantation. J Clin Med. 2022; 11(20). PMC: 9605224. DOI: 10.3390/jcm11206148. View

17.

Wang J, Xu L, Yun X, Yang K, Liao D, Tian L . Proteomic analysis reveals that proteasome subunit beta 6 is involved in hypoxia-induced pulmonary vascular remodeling in rats. PLoS One. 2013; 8(7):e67942. PMC: 3700908. DOI: 10.1371/journal.pone.0067942. View

18.

Nieuwenhuijs-Moeke G, Pischke S, Berger S, Sanders J, Pol R, Struys M . Ischemia and Reperfusion Injury in Kidney Transplantation: Relevant Mechanisms in Injury and Repair. J Clin Med. 2020; 9(1). PMC: 7019324. DOI: 10.3390/jcm9010253. View

19.

De Martino M, Hoetzenecker K, Ankersmit H, Roth G, Haitel A, Waldert M . Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis. Br J Cancer. 2012; 106(5):904-8. PMC: 3305962. DOI: 10.1038/bjc.2012.20. View

20.

Lv J, Zhang L . Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019; 1165:3-15. DOI: 10.1007/978-981-13-8871-2_1. View